Addressing these issues often involves treatments designed to restore collagen and improve skins elasticity to enhance facial appearance
All you need to do is complete an online assessment, at your convenience
As retatrutide isnt approved yet, we cant say for sure
Aka pancreatitis
This delay is therapeutically useful it extends satiety and reduces caloric intake but it also causes the cramping, bloating, and abdominal pressure that researchers describe variously as "stomach pains on reta," "cramping on retatrutide," or simply that their "stomach hurts on reta." For the complete adverse event profile across all body systems, see our retatrutide side effects clinical data breakdown
Side Effects Comparison# Retatrutide Side Effects# Phase 2 data (n=338 obesity trial): Nausea : ~25% at higher doses (8-12 mg) Diarrhea : ~20% Vomiting : ~15% Constipation : Common Decreased appetite : Common (pharmacological effect) Heart rate : Small increase (2-4 bpm), potentially related to glucagon component Injection site reactions : Mild, transient Discontinuation rate : 6-10% due to adverse events The glucagon receptor component introduces theoretical concerns for hyperglycemia (counterbalanced by GLP-1/GIP in practice), cardiovascular effects (chronotropic glucagon action), and hepatic effects, none of which produced safety signals in Phase 2 but require larger-scale monitoring
